Finance

Beta
Lists
EMCURE:NSE
Emcure Pharmaceuticals Ltd
၁,၈၄၉.၀၀ ₹
+၁.၇၈%
(+၃၂.၄၀) 1D
ဇွန် ၂၄, GMT+၅:၃၀ ၁၅:၃၀:၀၄  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for EMCURE...
Open
၁,၈၂၀.၀၀ ₹
High
၁,၈၅၀.၀၀ ₹
Low
၁,၈၁၅.၀၀ ₹
Mkt. cap
ဋေ ၃.၅၁ သ
Avg. vol.
၁.၇၈ သိန်း
Volume
၁.၁၇ သိန်း
P/E ratio
၃၇.၉၁
52-wk high
၁,၈၅၀.၀၀ ₹
52-wk low
၁,၂၂၈.၉၀ ₹
EPS
၄၈.၇၇ ₹
No. of employees
၇ ထောင်
Open
၁,၈၂၀.၀၀ ₹
High
၁,၈၅၀.၀၀ ₹
Low
၁,၈၁၅.၀၀ ₹
Mkt. cap
ဋေ ၃.၅၁ သ
Avg. vol.
၁.၇၈ သိန်း
Volume
၁.၁၇ သိန်း
P/E ratio
၃၇.၉၁
52-wk high
၁,၈၅၀.၀၀ ₹
52-wk low
၁,၂၂၈.၉၀ ₹
EPS
၄၈.၇၇ ₹
No. of employees
၇ ထောင်
News stories
From sources across the web
THE ELEC, Korea Electronics Industry Media
THE ELEC, Korea Electronics Industry Media
·
ပြီးခဲ့သည့် ၃၃ မိနစ်
SK hynix Files ADR Registration Statement for Nasdaq Listing
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၁ နာရီ
Brenmiller Energy (NASDAQ: BNRG) seeks approval for BrenX rebrand, CEO terms and Alpha financing
Investor's Business Daily
Investor's Business Daily
·
ပြီးခဲ့သည့် ၂ နာရီ
Futures: Micron Soars On Results, Lifts Chips; Fed Inflation Data Due
Barron's
Barron's
·
ပြီးခဲ့သည့် ၄ နာရီ
SK Hynix Nasdaq Listing: Will the Memory Chip Giant Trigger a Price War?
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees၆.၇၃ ထောင်
Founded၁၉၈၁ ဧ ၁၆
Headquarters-
Sector-
Websiteemcure.com
Last report
၂၀၂၆ မေ ၅
Fiscal period
Q4 2026
EPS / Est. (INR)
၁၄.၇၀ ₹ / ၁၄.၇၀ ₹
+၀.၀၀%beat
Revenue / Est. (INR)
ဋေ ၂.၄၇ ထ / ဋေ ၂.၄၂ ထ
+၂.၀၆%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
ဋေ ၂.၁၀ ထ
ဋေ ၂.၂၇ ထ
ဋေ ၂.၃၆ ထ
ဋေ ၂.၄၇ ထ
Cost of goods sold
၈၀၂.၀၁ ဋေ
၈၈၉.၅၃ ဋေ
၉၆၂.၄၃ ဋေ
ဋေ ၁.၀၀ ထ
Cost of revenue
၈၀၂.၀၁ ဋေ
၈၈၉.၅၃ ဋေ
၉၆၂.၄၃ ဋေ
ဋေ ၁.၀၀ ထ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃၉၃.၄၇ ဋေ
၃၈၄.၆၂ ဋေ
၃၈၇.၃၃ ဋေ
၃၈၆.၇၈ ဋေ
Operating expense
၉၉၄.၀၉ ဋေ
ဋေ ၁.၀၅ ထ
ဋေ ၁.၀၅ ထ
ဋေ ၁.၀၉ ထ
Total operating expenses
ဋေ ၁.၈၀ ထ
ဋေ ၁.၉၄ ထ
ဋေ ၂.၀၁ ထ
ဋေ ၂.၀၉ ထ
Operating income
၃၀၄.၄၃ ဋေ
၃၃၄.၄၈ ဋေ
၃၅၅.၄၄ ဋေ
၃၇၉.၂၁ ဋေ
Other non operating income
၃.၇၀ ကုဋေ
၃.၁၂ ကုဋေ
၁.၈၅ ကုဋေ
၃.၉၉ ကုဋေ
EBT including unusual items
၂၉၀.၇၆ ဋေ
၃၄၁.၄၂ ဋေ
၃၁၃.၇၉ ဋေ
၃၄၁.၁၈ ဋေ
EBT excluding unusual items
၂၉၄.၂၆ ဋေ
၃၄၁.၄၂ ဋေ
၃၅၁.၉၄ ဋေ
၃၇၃.၇၄ ဋေ
Income tax expense
၇၅.၉၆ ကုဋေ
၉၀.၀၅ ကုဋေ
၈၂.၄၂ ကုဋေ
၉၇.၄၄ ကုဋေ
Effective tax rate
၂၆.၁၃%
၂၆.၃၇%
၂၆.၂၇%
၂၈.၅၆%
Other operating expenses
၅၀၁.၁၆ ဋေ
၅၅၆.၅၅ ဋေ
၅၅၃.၆၀ ဋေ
၅၉၄.၃၆ ဋေ
Net income
၂၀၆.၉၅ ဋေ
၂၄၃.၄၆ ဋေ
၂၃၀.၅၄ ဋေ
၂၄၃.၄၀ ဋေ
Net profit margin
၉.၈၅%
၁၀.၇၃%
၉.၇၅%
၉.၈၆%
Earnings per share
၁၁.၀၆
၁၂.၈၅
၁၃.၆၇
၁၄.၇၀
Interest and investment income
-
-
-
-
Interest expense
-၂၆.၇၆ ကုဋေ
-၃၂.၅၄ ကုဋေ
-၃၇.၉၈ ကုဋေ
-၄၆.၄၀ ကုဋေ
Net interest expenses
-၂၆.၇၆ ကုဋေ
-၃၂.၅၄ ကုဋေ
-၃၇.၉၈ ကုဋေ
-၄၆.၄၀ ကုဋေ
Depreciation and amortization charges
၉၉.၄၆ ကုဋေ
၁၀၄.၆၄ ဋေ
၁၀၄.၆၈ ဋေ
၁၀၆.၂၇ ဋေ
EBITDA
၃၈၆.၂၈ ဋေ
၄၃၆.၅၃ ဋေ
၄၃၇.၂၉ ဋေ
၄၈၂.၉၇ ဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer